Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
140000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of performance-linked Third Series paid stock acquisition rights (paid stock options)
発行・処分する株式数
140,000 shares (1,400 stock acquisition rights, 100 shares per right)
Intended allottee
Name The Company's executive officers and employees / Number of Employees 6 / Number of stock acquisition rights 1,400 rights
¥1,600 per stock acquisition right, or ¥16 per underlying share
Total issue value
¥2,240,000 (assuming 1,400 rights are allotted)
発行済株式総数
Increase of 140,000 shares (if all rights are exercised)
Approximately 0.24% (if all rights are exercised)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Initially ¥515 per share. Adjustment provisions apply in the event of a share split or consolidation, the issuance of new shares below market value, or similar events. The floor for adjustments is Not disclosed.
Exercise period
From the later of the first day of the month following the filing date of the securities report for the fiscal year ending July 2030 and the day following the conclusion of the annual general meeting of shareholders for that fiscal year, until 9 September 2032
Number of Stock Acquisition Rights
Total number issued: 1,400. The number of outstanding unexercised rights is Not disclosed.
Reason for acquisition without consideration
If approval or other authorization is granted for a corporate reorganization, or if the rights become unexercisable under the exercise conditions or for other reasons, the Company may acquire all or part of these stock acquisition rights for no consideration. If payment is not made by the payment date, the rights will lapse.
Categories and Number of Persons Covered
The Company's executive officers and employees: 6 people, 1,400 rights
Payment date
9 October 2026
Basis for determining the amount to be paid
The issue price of the stock acquisition rights is equal to their fair value calculated by an independent valuation institution using a Monte Carlo simulation based on share price information and other data. The exercise price is the closing price of ¥515 in ordinary trading on the TSE Prime Market on 21 August 2026. The discount rate and premium rate are Not disclosed.
Procedures under the Corporate Code of Conduct
Because the rights are issued for consideration at fair value and do not constitute particularly favorable terms, the issuance will be conducted without shareholder approval.
Most recent equity financing
Resolution dated 24 August 2026: Second Series paid stock acquisition rights issued through a third-party allotment, Resolution dated 24 August 2026: Fifth Series gratis stock acquisition rights for employees
Impact on Business Performance
The specific impact of the issuance of these stock acquisition rights on business performance is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of performance-linked Third Series paid stock acquisition rights (paid stock options) |
| Number of shares to be issued or disposed of | 140,000 shares (1,400 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | ¥1,600 per stock acquisition right, or ¥16 per underlying share |
| Total issue value | ¥2,240,000 (assuming 1,400 rights are allotted) |
| Payment date | 9 October 2026 |
| Intended allottee | Name The Company's executive officers and employees / Number of Employees 6 / Number of stock acquisition rights 1,400 rights |
| Dilution Rate | Approximately 0.24% (if all rights are exercised) |
| Total number of issued shares | Increase of 140,000 shares (if all rights are exercised) |
| Basis for determining the amount to be paid | The issue price of the stock acquisition rights is equal to their fair value calculated by an independent valuation institution using a Monte Carlo simulation based on share price information and other data. The exercise price is the closing price of ¥515 in ordinary trading on the TSE Prime Market on 21 August 2026. The discount rate and premium rate are Not disclosed. |
| Exercise price | Initially ¥515 per share. Adjustment provisions apply in the event of a share split or consolidation, the issuance of new shares below market value, or similar events. The floor for adjustments is Not disclosed. |
| Exercise period | From the later of the first day of the month following the filing date of the securities report for the fiscal year ending July 2030 and the day following the conclusion of the annual general meeting of shareholders for that fiscal year, until 9 September 2032 |
| Number of Stock Acquisition Rights | Total number issued: 1,400. The number of outstanding unexercised rights is Not disclosed. |
| Reason for acquisition without consideration | If approval or other authorization is granted for a corporate reorganization, or if the rights become unexercisable under the exercise conditions or for other reasons, the Company may acquire all or part of these stock acquisition rights for no consideration. If payment is not made by the payment date, the rights will lapse. |
| Categories and Number of Persons Covered | The Company's executive officers and employees: 6 people, 1,400 rights |
| Procedures under the Corporate Code of Conduct | Because the rights are issued for consideration at fair value and do not constitute particularly favorable terms, the issuance will be conducted without shareholder approval. |
| Most recent equity financing | Resolution dated 24 August 2026: Second Series paid stock acquisition rights issued through a third-party allotment, Resolution dated 24 August 2026: Fifth Series gratis stock acquisition rights for employees |
| Impact on Business Performance | The specific impact of the issuance of these stock acquisition rights on business performance is Not disclosed. |
Items this document does not state (11)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To have officers and employees invest their own funds and bear the associated economic risk, thereby clarifying their commitment to achieving performance targets and aligning their economic interests with those of shareholders.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.